Suppr超能文献

高渗刺激通过抑制共培养系统中 RANKL 的表达来下调 1α,25-二羟维生素 D(3)诱导的破骨细胞生成。

Hyperosmotic Stimulus Down-regulates 1alpha, 25-dihydroxyvitamin D(3)-induced Osteoclastogenesis by Suppressing the RANKL Expression in a Co-culture System.

机构信息

Department of Oral Biology, Yonsei University, Seoul 120-752, Korea.

出版信息

Korean J Physiol Pharmacol. 2010 Jun;14(3):169-76. doi: 10.4196/kjpp.2010.14.3.169. Epub 2010 Jun 30.

Abstract

The hyperosmotic stimulus is regarded as a mechanical factor for bone remodeling. However, whether the hyperosmotic stimulus affects 1alpha, 25-dihydroxyvitamin D(3) (1alpha,25(OH)(2)D(3))-induced osteoclastogenesis is not clear. In the present study, the effect of the hyperosmotic stimulus on 1alpha,25(OH)(2)D(3)-induced osteoclastogenesis was investigated in an osteoblast-preosteoclast co-culture system. Serial doses of sucrose were applied as a mechanical force. These hyperosmotic stimuli significantly evoked a reduced number of 1alpha,25(OH)(2)D(3)-induced tartrate-resistant acid phosphatase-positive multinucleated cells and 1alpha,25(OH)(2)D(3)-induced bone-resorbing pit area in a co-culture system. In osteoblastic cells, receptor activator of nuclear factor kappaB ligand (RANKL) and Runx2 expressions were down-regulated in response to 1alpha,25(OH)(2)D(3). Knockdown of Runx2 inhibited 1alpha,25(OH)(2)D(3)-induced RANKL expression in osteoblastic cells. Finally, the hyperosmotic stimulus induced the overexpression of TonEBP in osteoblastic cells. These results suggest that hyperosmolarity leads to the down-regulation of 1alpha,25(OH)(2)D(3)-induced osteoclastogenesis, suppressing Runx2 and RANKL expression due to the TonEBP overexpression in osteoblastic cells.

摘要

高渗刺激被认为是骨重建的机械因素。然而,高渗刺激是否影响 1α,25-二羟维生素 D(3)(1α,25(OH)(2)D(3))诱导的破骨细胞生成尚不清楚。在本研究中,在成骨细胞-前破骨细胞共培养系统中研究了高渗刺激对 1α,25(OH)(2)D(3)诱导的破骨细胞生成的影响。连续剂量的蔗糖被用作机械力。这些高渗刺激在共培养系统中显著引发了 1α,25(OH)(2)D(3)诱导的抗酒石酸酸性磷酸酶阳性多核细胞和 1α,25(OH)(2)D(3)诱导的骨吸收陷窝面积的减少。在成骨细胞中,核因子 kappaB 受体激活剂配体(RANKL)和 Runx2 的表达在受到 1α,25(OH)(2)D(3)的刺激后下调。Runx2 的敲低抑制了成骨细胞中 1α,25(OH)(2)D(3)诱导的 RANKL 表达。最后,高渗刺激诱导了成骨细胞中 TonEBP 的过表达。这些结果表明,高渗导致 1α,25(OH)(2)D(3)诱导的破骨细胞生成的下调,由于成骨细胞中 TonEBP 的过表达,抑制了 Runx2 和 RANKL 的表达。

相似文献

4
Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells.
Biochem Biophys Res Commun. 2004 Nov 12;324(2):655-60. doi: 10.1016/j.bbrc.2004.09.101.
5
Modulation of mouse RANKL gene expression by Runx2 and vitamin D3.
J Cell Biochem. 2008 Dec 1;105(5):1289-97. doi: 10.1002/jcb.21929.
7
Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells.
Arch Oral Biol. 2011 Sep;56(9):924-31. doi: 10.1016/j.archoralbio.2011.02.002. Epub 2011 Mar 5.
8
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
10

引用本文的文献

1
Effects of Inositol 1,4,5-triphosphate on Osteoclast Differentiation in RANKL-induced Osteoclastogenesis.
Korean J Physiol Pharmacol. 2012 Feb;16(1):31-6. doi: 10.4196/kjpp.2012.16.1.31. Epub 2012 Feb 28.

本文引用的文献

1
TonEBP/OREBP is a regulator of nucleus pulposus cell function and survival in the intervertebral disc.
J Biol Chem. 2006 Sep 1;281(35):25416-24. doi: 10.1074/jbc.M601969200. Epub 2006 Jun 13.
5
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6.
6
Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells.
Biochem Biophys Res Commun. 2004 Nov 12;324(2):655-60. doi: 10.1016/j.bbrc.2004.09.101.
7
Genetic regulation of osteoclast development and function.
Nat Rev Genet. 2003 Aug;4(8):638-49. doi: 10.1038/nrg1122.
8
Osteoclast differentiation and activation.
Nature. 2003 May 15;423(6937):337-42. doi: 10.1038/nature01658.
9
Tensegrity II. How structural networks influence cellular information processing networks.
J Cell Sci. 2003 Apr 15;116(Pt 8):1397-408. doi: 10.1242/jcs.00360.
10
RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
J Pathol. 2002 Oct;198(2):228-36. doi: 10.1002/path.1199.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验